Journal of Health Economics and Outcomes Research

Featured Articles

Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain

Authors: Carlos Rubio-Terrés1, Ruth Graefenhain de Codes2, Darío Rubio-Rodríguez1, Thomas Evers3, Santiago Grau Cerrato4

JHEOR 2016;4(1):19-34

Register or Login to Read More

Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain

Authors: Xavier Granero Xiberta1, Antonio Murcia2, José Ricardo Troncoso Durán3, Claudio Gómez Zubeldia4, Aleix Llorac Moix5, Ruth Graefenhain De Codes5, Maria Giovana Ferrario6, Luis Lizán6

JHEOR 2016;4(1):35-46 

Register or Login to Read More

Competing Risks Analysis of Cancer-associated Recurrent Thrombosis, Major Bleeds, and Death in a Geriatric Cohort

Authors: Joshua D. Brown1,2, Kelley L. Ratermann2, Jeffery C. Talbert1,2, Val R. Adams2

JHEOR 2015;3(2):214-23

Register or Login to Read More

Most Viewed

Health Care Costs attributable to Hospital-diagnosed Back Pain: A Longitudinal Register-based Study of the Danish Population

Authors: Rikke Søgaard1, Jan Sørensen1

JHEOR 2014;1(3):266-75

Register or Login to Read More

Generalized Propensity Score Matching with Multilevel Treatment Options

Author: Onur Baser

JHEOR 2013; 1(1):1-13

Register or Login to Read More

Anti-vascular Endothelial Growth Factor Outpatient Treatment Patterns in Patients with Exudative Age-related Macular Degeneration from a Japanese Hospital Claims Database

Authors: Tomohiro Iida1, Aya Narimatsu2, Kenji Adachi2, Edward CY Wang2

JHEOR 2014;2(1):41-52

Register or Login to Read More

Latest Articles

Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain

Authors: Carlos Rubio-Terrés1, Ruth Graefenhain de Codes2, Darío Rubio-Rodríguez1, Thomas Evers3, Santiago Grau Cerrato4

JHEOR 2016;4(1):19-34

Register or Login to Read More

Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain

Authors: Xavier Granero Xiberta1, Antonio Murcia2, José Ricardo Troncoso Durán3, Claudio Gómez Zubeldia4, Aleix Llorac Moix5, Ruth Graefenhain De Codes5, Maria Giovana Ferrario6, Luis Lizán6

JHEOR 2016;4(1):35-46 

Register or Login to Read More

Competing Risks Analysis of Cancer-associated Recurrent Thrombosis, Major Bleeds, and Death in a Geriatric Cohort

Authors: Joshua D. Brown1,2, Kelley L. Ratermann2, Jeffery C. Talbert1,2, Val R. Adams2

JHEOR 2015;3(2):214-23

Register or Login to Read More

Journal of Health Economics and Outcomes Research
An A2 Publications Journal
211 N. 4th Avenue, Suite 2A
Ann Arbor, MI 48104

Phone: 1-734-392-4850 Fax: 1-734-864-0308

Back to Top